Waterborne manganese exposure alters plasma, brain, and liver metabolites accompanied by changes in stereotypic behaviors

Neurotoxicology and Teratology

Volumn 34, Issue 1, 2012, Pages 27-36

  Fordahl, Steve ^a   Cooney, Paula ^a   Qiu, Yunping ^a   Xie, Guoxiang ^a   Jia, Wei ^a   Erikson, Keith M ^a  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Behavior; Biomarker; Circadian rhythm; Manganese; Metabolomics; Neurotoxicity

Indexed keywords

ASPARTIC ACID; BIOLOGICAL MARKER; CHENODEOXYCHOLIC ACID; FATTY ACID; HYDROXYBUTYRIC ACID; MANGANESE; OLEIC ACID; PALMITIC ACID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR CHANGE; BIOLOGICAL MONITORING; BLOOD LEVEL; BRAIN METABOLISM; CHOLESTEROL METABOLISM; CIRCADIAN RHYTHM; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; FATTY ACID METABOLISM; GAS CHROMATOGRAPHY; GLOBUS PALLIDUS; LIGHT DARK CYCLE; LIQUID CHROMATOGRAPHY; LIVER METABOLISM; LOCOMOTION; LONG TERM EXPOSURE; MALE; METABOLITE; METABOLOME; METABOLOMICS; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; STEREOTYPY; STRIATE CORTEX; TIME OF FLIGHT MASS SPECTROMETRY; TOXICITY TESTING;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; DISEASE MODELS, ANIMAL; LIVER; MALE; MANGANESE; MANGANESE POISONING; RATS; RATS, SPRAGUE-DAWLEY; STEREOTYPED BEHAVIOR; WATER POLLUTANTS, CHEMICAL;

RATTUS;

EID: 82655169242     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2011.10.003     Document Type: Article

References (62)

1. Anderson J.G., Cooney P.T., Erikson K.M. Inhibition of DAT function attenuates manganese accumulation in the globus pallidus. Environ Toxicol Pharmacol 2007, 23:179-184.
2. Anderson J.G., Fordahl S.C., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Manganese exposure alters extracellular GABA, GABA receptor and transporter protein and mRNA levels in the developing rat brain. NeuroTox 2008, 29:1044-1053.
3. Baquer N.Z., Nothersall J.S., Greenbaum A.L., McLean P. The modifying effect of manganese on the enzymic profiles and pathways of carbohydrate metabolism in rat liver and adipose tissue during development. Biochem Biophys Res Commun 1974, 62(3):634-641.
4. Bouchard M.F., Laforest F., Vandelac L., Bellinger D., Mergler D. Hair manganese and hyperactive behaviors: pilot study of school-age children exposed through tap water. EHP 2007, 115(1):122-127.
5. Bouchard M.F., Sauve S., Barbeau B., Legrand M., Brodeur M., Bouffard T., Limoges E., Bellinger D.C., Mergler D. Intellectual impairment in school-age children exposed to manganese from drinking water. EHP 2011, 119(1):138-143.
6. Brock A.A., Chapman S.A., Ulman E.A., Wu G. Dietary manganese deficiency decreases rat hepatic arginase activity. J Nutr 1994, 124(3):340-344.
7. Cai T., Che H., Yao T., Chen Y., Huang C., Zhang W., Du K., Zhang J., Cao Y., Chen J., Luo W. Manganese induces tau hyperphosphorylation through the activation of ERK MAPK pathway in PC12 cells. Toxicol Sci 2011, 119(1):169-177.
8. Calabresi P., Ammassari-Teule M., Gubellin P., Sancesario G., Morello M., Centonze D., Marfia G.A., Saulle E., Passino E., Picconi B., Bernardi G. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiol Dis 2001, 8:419-432.
9. Castaneda T.R., de Prado B.M., Prieto D., Francisco M. Circadian rhythms of dopamine, glutamate and GABA in the striatum and nucleus accumbens of the awake rat: modulation by light. J Pineal Res 2004, 177-185.
10. Cersosimo M.G., Koller W.C. The diagnosis of manganese-induced parkinsonism. NeuroTox 2006, 27:340-346.
11. Chua A.C., Morgan E.H. Effects of iron deficiency and iron overload on manganese uptake and deposition in the brain and other organs of the rat. Biol Trace Elem Res 1996, 55(1-2):39-54.
12. Chun H.S., Lee H., Son J.H. Manganese induces endoplasmic reticulum (ER) stress and activates multiple caspases in nigral dopaminergic neuronal cells, SN4741. Neurosci Lett 2001, 316:5-8.
13. Cowan D.M., Zheng W., Zou Y., Shi X., Chen J., Rosenthal F.S., Fan Q. Manganese exposure among smelting workers: relationship between blood manganese-iron ratio and early onset neurobehavioral alterations. NeuroTox 2009, 30(6):1214-1222.
14. Crossgrove J., Zheng W. Manganese toxicity upon overexposure. NMR Biomed 2004, 17:544-553.
15. Davis C.D., Greger J.L. Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am J Clin Nutr 1992, 55(3):747-752.
16. de Haas R., Nijdam A., Westra T.A., Kas M.J.H., Westenberg H.G.M. Behavioral pattern analysis and dopamine release in quinpirole-induced repetitive behavior in rats. J Psychopharmacol 2010, 1-8.
17. Demougeot C., Garnier Pl, Mossiat C., Bertrand N., Giroud M., Beley A., Marie C. N-Acetylaspartate, a marker of both cellular dysfunction and neuronal loss: its relevance to studies of acute brain injury. J Neurochem 2001, 77(2):408-415.
18. Dorman C.D., Struve M.F., Wong A.W., Dye J.A., Robertson I.D. Correlation of brain magnetic resonance imaging changes with pallidal manganese concentrations in rhesus monkeys following subchronic manganese inhalation. Toxicol Sci 2006, 92(1):219-227.
19. Dorman C.D., Struve M.F., Norris A., Higgings A.J. Metabolomic analyses of body fluids after subchronic manganese inhalation in rhesus monkeys. Toxicol Sci 2008, 106(1):46-54.
20. Erikson K.M., Syversen T., Steinnes E., Aschner M. Globus pallidus: a target region for divalent metal accumulation associated with dietary iron deficiency. J Nutr Biochem 2004, 15:335-341.
21. Erikson K.M., Dorman D.C., Lash L.H., Aschner M. Manganese inhalation by rhesus monkeys is associated with brain regional changes in biomarkers of neurotoxicity. Toxicol Sci 2007, 97(2):459-466.
22. Farias A.C., Cunha A., Benko C.R., McCracken J.T., Costa M.T., Farias L.G., Cordeiro M.L. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure. J Child Adolesc Psychopharmacol 2010, 20(2):113-118.
23. Fitsanakis V.A., Au C., Erikson K.M., Aschner M. The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation. Neurochem Int 2006, 48:426-433.
24. Fitsanakis V.A., Zhang N., Anderson J.G., Erikson K.M., Avison M.J., Gore J.C., Aschner M. Measuring brain manganese and iron accumulation in rats following 14weeks of low-dose manganese treatment using atomic absorption spectroscopy and magnetic resonance imaging. Toxicol Sci 2008, 103(1):116-124.
25. Flagel S.B., Robinson T.E. Quantifying the psychomotor activating effects of cocaine in the rat. Behav Pharmacol 2007, 18:297-302.
26. Fordahl S.C., Anderson J.G., Cooney P.T., Weaver T.L., Colyer C.L., Erikson K.M. Manganese exposure inhibits the clearance of extracellular GABA and influences taurine homeostasis in the striatum of developing rats. NeuroTox 2010, 31:639-646.
27. Garcia S.J., Gellein K., Syversen T., Aschner M. A manganese-enhanced diet alters brain metals and transporters in the developing rat. Toxicol Sci 2006, 92(2):516-525.
28. Gianutsos G., Murray M.T. Alterations in brain dopamine and GABA following inorganic or organic manganese administration. NeuroTox 1982, 3:75-81.
29. 1H-MRS and MRI study. Toxicol Sci 2006, 94(2):351-358.
30. Halket J.M., Waterman D., Przyborowska A.M., Patel R.K.P., Fraser P.D., Bramley P.M. Chemical derivatization and mass spectral libraries in metabolic profiling by GC/MS and LC/MS/MS. J Exp Bot 2005, 56(410):219-243.
31. Harkness J.E., Wagner J.E. The biology and medicine of rabbits and rodents 1989, Lea and Febiger, Philadelphia. 3rd edition.
32. HMDB Human metabolome database web site Accessed: January 18, 2011. http://www.hmdb.ca/.
33. Hurley L.S., Keen C.L. Trace elements in human and animal nutrition 1987, 185-223. Academic Press, San Diego, CA, vol. 1. 5th ed. W. Mertz (Ed.).
34. Kawamura R., Ikuta H., Fukuzumi S., Yamada R., Tsubaki S. Intoxication by manganese in well water. Kitasato Arch Exp Med 1941, 18:145-171.
35. Kern C.H., Stanwood G.D., Smith D.R. Preweaning manganese exposure causes hyperactivity, disinhibition, and spatial learning and memory deficits associated with altered dopamine receptor and transporter levels. Synapse 2010, 64:363-378.
36. Kim Y., Kim J.W., Ito K., Hisanaga N., Cheong H.K., Kim K.S., Moon Y. Positron emission tomography (PET) in differentiating manganism from idiopathic Parkinsonism. J Occup Health 1999, 41:91-94.
37. Kim Y.S., Maruvada P., Milner J.A. Metabolimics in biomarker discovery: future uses for cancer prevention. Future Oncol 2008, 4(1):93-102.
38. NTP Toxicology and carcinogenesis studies of manganese (II) sulfate monohydrate in F344/N rats and B6C3F1 mice (feed study). National toxicology program. Technical report series 428. RISKLINE 94030007 1993.
39. O'Donoghue J.L. Clinical neurologic indices of toxicity in animals. Environ Health Perspect 1996, 104(Suppl. 2):323-330.
40. Oresic M., Vidal-Puig A., Hanninen V. Metabolomic approaches to phenotype characterization and applications to complex diseases. Expert Rev Mol Diagn 2006, 6(4):575-585.
41. Pal P.K., Samii A., Calne D.B. Manganese neurotoxicity: a review of clinical features, imaging and pathology. NeuroTox 1999, 20:227-238.
42. Pan L., Qiu Y., Chen T., Lin J., Chi Y., Su M., Zhao A., Jia W. An optimized procedure for metabonomic analysis of rat liver tissue using gas chromatography/time-of-flight mass spectrometry. J Pharm Biomed Anal 2010, 52(4):589-596.
43. Patil S., Melrose J., Chan C. Involvement of astroglial ceramide in palmitic acid-induced Alzheimer-like changes in primary neurons. Eur J Neurosci 2007, 26:2131-2141.
44. Patil S., Balu D., Melrose J., Chan C. Brain region-specificity of palmitic acid-induced abnormalities associated with Alzheimer's disease. BMC Res Notes 2008, 1:20.
45. Perl D.P., Olanow C.W. The neuropathology of manganese-induced Parkinsonism. J Neuropathol Exp Neurol 2007, 66(8):675-682.
46. Pradat P.F., Dib M. Biomarkers in amyotrophic lateral sclerosis: facts and future horizons. Mol Diagn Ther 2009, 13(2):115-125.
47. Qiu Y., Cai G., Su M., Chen T., Zheng X., Xu Y., Ni Y., Zhao A., Xu L.X., Cai S., Jia W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res 2009, 8(10):4844-4850.
48. Reghunandanan V., Reghunandanan R. Neurotransmitters of the suprachiasmatic nuclei. J Circadian Rhythm 2006, 4(2):1-20.
49. Ronchetti I.P., Contri M.B. Elastic fiber during development and aging. Microsc Res Tech 1997, 38:428-435.
50. Scheer F.A., Kalsbeek A., Buijs R.M. Cardiovascular control by the suprachiasmatic nucleus: neural and neuroendocrine mechanisms in human and rat. Biol Chem 2003, 384:697-709.
51. Schneider J.S., Decamp E., Koser A.J., Fritz S., Gonczi H., Syversen T., Guilarte T.R. Effects of chronic manganese exposure on cognitive and motor functioning in non-human primates. Brain Res 2006, 1118(1):222-231.
52. Scorpio R.M., Masoro E.J. Differences between manganese and magnesium ions with regard to fatty acid biosynthesis, acetyl-coenzyme a carboxylase activity and malonyl-coenzyme A decarboxylation. Biochem J 1970, 118:391-399.
53. Shobab L.A., Hsiung G.Y.R., Feldman H.H. Cholesterol in Alzheimer's disease. Lancet Neurol 2005, 4:841-852.
54. Steele A.D., Jackson W.S., King O.D., Lindquist S. The power of automated high-resolution behavior analysis revealed by its application to mouse models of Huntington's and prion diseases. PNAS 2007, 104:1983-1988.
55. Suzuki K., Miyamoto M., Miyamoto T., Iwanami M., Hirata K. Sleep disturbances associated with Parkinson's disease. Park Dis 2011, 2011(219056):1-10.
56. Tjalkens R.B., Zoran M.J., Mohl B., Barhoumi R. Manganese suppresses ATP-dependent intercellular calcium waves in astrocyte networks through alteration of mitochondrial and endoplasmic reticulum calcium dynamics. Brain Res 2006, 1113:210-219.
57. Vacher C.M., Gassmann M., Desrayaud S., Challet E., Bradaia A., Hoyer D., Waldmeier P., Kaupmann K., Pévet P., Bettler B. Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J Neurochem 2006, 97:979-991.
58. Wagner S., Sagiv N., Yarom Y. GABA-induced current and circadian regulation of chloride in neurones of the rat suprachiasmatic nucleus. J Physiol 2001, 537(3):853-869.
59. Wasserman G.A., Liu X., Parvez F., Ahsan H., Levy D., Factor-Litvak P., Kline J., van Geen A., Slavkovich V., Lolacono N.J., Cheng Z., Zheng Y., Graziano J.H. Water manganese exposure and children's intellectual function in Araihazar, Bangladesh. Environ Health Perspect 2006, 114:124-129.
60. Witholt R., Gwiazda R.H., Smith D.R. The neurobehavioral effects of subchronic manganese exposure in the presence and absence of pre-parkinsonism. Neurotoxicol Teratol 2000, 22:851-861.
61. Youdim M.B., Yehuda S. Iron deficiency induces reversal of dopamine dependent circadian cycles: differential resonse to d-amphatamine and TRH. Peptides 1985, 6:851-855.
62. Youdim M.B., Green A.R., Bloomfield M.R., Mitchell B.D., Heal D.J., Grahame-Smith D.G. The effects of iron deficiency on brain biogenic monoamine biochemistry and function in rats. Neuropharmacology 1980, 19:259-267.